nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—Haloperidol—H1F0—ocular cancer	0.0345	1	CrCbGaD
Loperamide—CALM2—ear—ocular cancer	0.0115	0.136	CbGeAlD
Loperamide—CALM1—ear—ocular cancer	0.0115	0.135	CbGeAlD
Loperamide—CALM2—pineal body—ocular cancer	0.00998	0.117	CbGeAlD
Loperamide—CALM1—pineal body—ocular cancer	0.00994	0.117	CbGeAlD
Loperamide—POMC—lymphoid tissue—ocular cancer	0.00782	0.092	CbGeAlD
Loperamide—CALM3—eye—ocular cancer	0.00386	0.0454	CbGeAlD
Loperamide—CALM3—retina—ocular cancer	0.00382	0.045	CbGeAlD
Loperamide—CALM2—eye—ocular cancer	0.00303	0.0357	CbGeAlD
Loperamide—CALM1—eye—ocular cancer	0.00302	0.0355	CbGeAlD
Loperamide—CALM2—retina—ocular cancer	0.003	0.0353	CbGeAlD
Loperamide—CALM1—retina—ocular cancer	0.00299	0.0352	CbGeAlD
Loperamide—CALM2—epithelium—ocular cancer	0.00277	0.0326	CbGeAlD
Loperamide—CALM1—epithelium—ocular cancer	0.00276	0.0325	CbGeAlD
Loperamide—CALM2—lymphoid tissue—ocular cancer	0.00214	0.0251	CbGeAlD
Loperamide—CALM1—lymphoid tissue—ocular cancer	0.00213	0.025	CbGeAlD
Loperamide—CYP2B6—lymphoid tissue—ocular cancer	0.00159	0.0187	CbGeAlD
Loperamide—ABCB1—retina—ocular cancer	0.00119	0.014	CbGeAlD
Loperamide—ABCB1—epithelium—ocular cancer	0.0011	0.013	CbGeAlD
Loperamide—ABCB1—lymphoid tissue—ocular cancer	0.000848	0.00998	CbGeAlD
Loperamide—CALM1—Signaling by Wnt—MYC—ocular cancer	0.000324	0.000368	CbGpPWpGaD
Loperamide—CALM3—Disease—HDAC1—ocular cancer	0.000321	0.000364	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GNA11—ocular cancer	0.000321	0.000364	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000317	0.00036	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000317	0.00036	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000312	0.000355	CbGpPWpGaD
Loperamide—CALM1—Disease—HDAC1—ocular cancer	0.00031	0.000352	CbGpPWpGaD
Loperamide—CALM2—Disease—HDAC1—ocular cancer	0.00031	0.000352	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GNA11—ocular cancer	0.00031	0.000352	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GNA11—ocular cancer	0.00031	0.000352	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00031	0.000352	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—AKT1—ocular cancer	0.000307	0.000349	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAML2—ocular cancer	0.000307	0.000349	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GNAQ—ocular cancer	0.000306	0.000348	CbGpPWpGaD
Loperamide—CALM3—RNF mutants show enhanced WNT signaling and proliferation—AKT1—ocular cancer	0.000303	0.000344	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.0003	0.00034	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.0003	0.00034	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—E2F1—ocular cancer	0.000299	0.000339	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GNAQ—ocular cancer	0.000298	0.000338	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—AKT1—ocular cancer	0.000297	0.000338	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAML2—ocular cancer	0.000297	0.000337	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAML2—ocular cancer	0.000297	0.000337	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MDM2—ocular cancer	0.000297	0.000337	CbGpPWpGaD
Loperamide—CALM2—RNF mutants show enhanced WNT signaling and proliferation—AKT1—ocular cancer	0.000293	0.000333	CbGpPWpGaD
Loperamide—CALM1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—ocular cancer	0.000293	0.000333	CbGpPWpGaD
Loperamide—CALM3—Neuronal System—HRAS—ocular cancer	0.000291	0.000331	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GNAQ—ocular cancer	0.000288	0.000327	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GNAQ—ocular cancer	0.000288	0.000327	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN2B—ocular cancer	0.000288	0.000327	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MDM2—ocular cancer	0.000287	0.000326	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MDM2—ocular cancer	0.000287	0.000326	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—HRAS—ocular cancer	0.000285	0.000324	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—MDM2—ocular cancer	0.000285	0.000323	CbGpPWpGaD
Loperamide—CALM2—Neuronal System—HRAS—ocular cancer	0.000282	0.00032	CbGpPWpGaD
Loperamide—CALM1—Neuronal System—HRAS—ocular cancer	0.000282	0.00032	CbGpPWpGaD
Loperamide—CALM3—Signaling by WNT in cancer—AKT1—ocular cancer	0.000281	0.00032	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GNA11—ocular cancer	0.000279	0.000317	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN2B—ocular cancer	0.000278	0.000316	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN2B—ocular cancer	0.000278	0.000316	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—HRAS—ocular cancer	0.000276	0.000313	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—HRAS—ocular cancer	0.000276	0.000313	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—MDM2—ocular cancer	0.000275	0.000313	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—MDM2—ocular cancer	0.000275	0.000313	CbGpPWpGaD
Loperamide—CALM2—Signaling by WNT in cancer—AKT1—ocular cancer	0.000272	0.000309	CbGpPWpGaD
Loperamide—CALM1—Signaling by WNT in cancer—AKT1—ocular cancer	0.000272	0.000309	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CDKN1B—ocular cancer	0.000271	0.000308	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GNA11—ocular cancer	0.000268	0.000304	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—EP300—ocular cancer	0.000264	0.0003	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000264	0.000299	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CDKN1B—ocular cancer	0.000262	0.000297	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CDKN1B—ocular cancer	0.000262	0.000297	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CDKN1B—ocular cancer	0.00026	0.000295	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GNA11—ocular cancer	0.000259	0.000294	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GNA11—ocular cancer	0.000259	0.000294	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000259	0.000294	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—EP300—ocular cancer	0.000255	0.00029	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—EP300—ocular cancer	0.000255	0.00029	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—AKT1—ocular cancer	0.000252	0.000286	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CDKN1B—ocular cancer	0.000252	0.000286	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CDKN1B—ocular cancer	0.000252	0.000286	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CDKN1A—ocular cancer	0.00025	0.000284	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GNAQ—ocular cancer	0.000249	0.000283	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—AKT1—ocular cancer	0.000244	0.000277	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—AKT1—ocular cancer	0.000244	0.000277	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MDM2—ocular cancer	0.000243	0.000276	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GNA11—ocular cancer	0.000243	0.000276	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CDKN1A—ocular cancer	0.000242	0.000275	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CDKN1A—ocular cancer	0.000242	0.000275	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GNAQ—ocular cancer	0.000241	0.000274	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GNAQ—ocular cancer	0.000241	0.000274	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CDKN1A—ocular cancer	0.00024	0.000273	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EP300—ocular cancer	0.000238	0.00027	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CDKN1A—ocular cancer	0.000232	0.000264	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CDKN1A—ocular cancer	0.000232	0.000264	CbGpPWpGaD
Loperamide—CALM3—Signaling by Wnt—AKT1—ocular cancer	0.000232	0.000264	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EP300—ocular cancer	0.00023	0.000261	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EP300—ocular cancer	0.00023	0.000261	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—ocular cancer	0.00023	0.000261	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GNA11—ocular cancer	0.000229	0.00026	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HRAS—ocular cancer	0.000226	0.000257	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GNAQ—ocular cancer	0.000226	0.000256	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HDAC1—ocular cancer	0.000225	0.000255	CbGpPWpGaD
Loperamide—CALM2—Signaling by Wnt—AKT1—ocular cancer	0.000224	0.000255	CbGpPWpGaD
Loperamide—CALM1—Signaling by Wnt—AKT1—ocular cancer	0.000224	0.000255	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000222	0.000252	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—ocular cancer	0.000222	0.000252	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—ocular cancer	0.000222	0.000252	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AKT1—ocular cancer	0.00022	0.00025	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HDAC1—ocular cancer	0.000217	0.000247	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HDAC1—ocular cancer	0.000217	0.000247	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MDM2—ocular cancer	0.000213	0.000242	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000213	0.000242	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCND1—ocular cancer	0.000212	0.000241	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000209	0.000238	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000205	0.000233	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN2B—ocular cancer	0.000201	0.000229	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—ocular cancer	0.0002	0.000227	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRAS—ocular cancer	0.000198	0.000225	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EP300—ocular cancer	0.000195	0.000222	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CDKN1B—ocular cancer	0.000195	0.000221	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN2B—ocular cancer	0.000195	0.000221	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN2B—ocular cancer	0.000195	0.000221	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—ocular cancer	0.000193	0.000219	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—ocular cancer	0.000189	0.000215	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCND1—ocular cancer	0.000186	0.000211	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—E2F1—ocular cancer	0.000185	0.00021	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—ocular cancer	0.000183	0.000208	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—ocular cancer	0.000183	0.000208	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—HRAS—ocular cancer	0.000181	0.000205	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MDM2—ocular cancer	0.00018	0.000205	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CDKN1A—ocular cancer	0.00018	0.000204	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—E2F1—ocular cancer	0.000179	0.000203	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—E2F1—ocular cancer	0.000179	0.000203	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—ocular cancer	0.000175	0.000199	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—HRAS—ocular cancer	0.000175	0.000199	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—HRAS—ocular cancer	0.000175	0.000199	CbGpPWpGaD
Loperamide—CALM3—Immune System—MDM2—ocular cancer	0.000173	0.000196	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EP300—ocular cancer	0.000171	0.000194	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MYC—ocular cancer	0.00017	0.000193	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—ocular cancer	0.00017	0.000193	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRAS—ocular cancer	0.000168	0.00019	CbGpPWpGaD
Loperamide—CALM2—Immune System—MDM2—ocular cancer	0.000167	0.00019	CbGpPWpGaD
Loperamide—CALM1—Immune System—MDM2—ocular cancer	0.000167	0.00019	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000165	0.000187	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—ocular cancer	0.000163	0.000185	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HRAS—ocular cancer	0.000163	0.000185	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—ocular cancer	0.00016	0.000181	CbGpPWpGaD
Loperamide—CALM3—Disease—MDM2—ocular cancer	0.000159	0.000181	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDKN1B—ocular cancer	0.000158	0.000179	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HRAS—ocular cancer	0.000157	0.000179	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HRAS—ocular cancer	0.000157	0.000179	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCND1—ocular cancer	0.000157	0.000178	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HRAS—ocular cancer	0.000156	0.000177	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—ocular cancer	0.000154	0.000175	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—ocular cancer	0.000154	0.000175	CbGpPWpGaD
Loperamide—CALM1—Disease—MDM2—ocular cancer	0.000154	0.000175	CbGpPWpGaD
Loperamide—CALM2—Disease—MDM2—ocular cancer	0.000154	0.000175	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDKN1B—ocular cancer	0.000153	0.000173	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDKN1B—ocular cancer	0.000153	0.000173	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000152	0.000173	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HRAS—ocular cancer	0.000151	0.000172	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HRAS—ocular cancer	0.000151	0.000172	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNA11—ocular cancer	0.00015	0.00017	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MYC—ocular cancer	0.000149	0.000169	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—ocular cancer	0.000149	0.000169	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—ocular cancer	0.000148	0.000168	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN1B—ocular cancer	0.000146	0.000165	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDKN1A—ocular cancer	0.000146	0.000165	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EP300—ocular cancer	0.000145	0.000164	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—ocular cancer	0.000144	0.000163	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN1B—ocular cancer	0.000141	0.00016	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN1B—ocular cancer	0.000141	0.00016	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDKN1A—ocular cancer	0.000141	0.00016	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDKN1A—ocular cancer	0.000141	0.00016	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—ocular cancer	0.00014	0.000159	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000139	0.000158	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—ocular cancer	0.000139	0.000158	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—ocular cancer	0.000139	0.000158	CbGpPWpGaD
Loperamide—CALM3—Immune System—EP300—ocular cancer	0.000138	0.000157	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—ocular cancer	0.000138	0.000157	CbGpPWpGaD
Loperamide—CALM3—Disease—CDKN1A—ocular cancer	0.000134	0.000153	CbGpPWpGaD
Loperamide—CALM1—Immune System—EP300—ocular cancer	0.000134	0.000152	CbGpPWpGaD
Loperamide—CALM2—Immune System—EP300—ocular cancer	0.000134	0.000152	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—ocular cancer	0.000134	0.000152	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—ocular cancer	0.000133	0.000152	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—ocular cancer	0.000133	0.000152	CbGpPWpGaD
Loperamide—CALM2—Disease—CDKN1A—ocular cancer	0.00013	0.000148	CbGpPWpGaD
Loperamide—CALM1—Disease—CDKN1A—ocular cancer	0.00013	0.000148	CbGpPWpGaD
Loperamide—CALM3—Disease—EP300—ocular cancer	0.000128	0.000145	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MYC—ocular cancer	0.000126	0.000143	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—ocular cancer	0.000126	0.000143	CbGpPWpGaD
Loperamide—CALM1—Disease—EP300—ocular cancer	0.000124	0.00014	CbGpPWpGaD
Loperamide—CALM2—Disease—EP300—ocular cancer	0.000124	0.00014	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—ocular cancer	0.000122	0.000139	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—ocular cancer	0.000118	0.000134	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—ocular cancer	0.000117	0.000133	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MDM2—ocular cancer	0.000112	0.000127	CbGpPWpGaD
Loperamide—CALM3—Disease—MYC—ocular cancer	0.000111	0.000127	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—ocular cancer	0.000111	0.000126	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—EP300—ocular cancer	0.00011	0.000125	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MDM2—ocular cancer	0.000108	0.000123	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MDM2—ocular cancer	0.000108	0.000123	CbGpPWpGaD
Loperamide—CALM2—Disease—MYC—ocular cancer	0.000108	0.000122	CbGpPWpGaD
Loperamide—CALM1—Disease—MYC—ocular cancer	0.000108	0.000122	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—ocular cancer	0.000108	0.000122	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—ocular cancer	0.000108	0.000122	CbGpPWpGaD
Loperamide—CALM3—Metabolism—EP300—ocular cancer	0.000107	0.000122	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—ocular cancer	0.000104	0.000118	CbGpPWpGaD
Loperamide—CALM1—Metabolism—EP300—ocular cancer	0.000104	0.000118	CbGpPWpGaD
Loperamide—CALM2—Metabolism—EP300—ocular cancer	0.000104	0.000118	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—ocular cancer	0.000104	0.000118	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—ocular cancer	0.000103	0.000117	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1B—ocular cancer	0.000102	0.000116	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—ocular cancer	0.0001	0.000114	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—ocular cancer	0.0001	0.000114	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—ocular cancer	9.9e-05	0.000112	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1B—ocular cancer	9.86e-05	0.000112	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1B—ocular cancer	9.86e-05	0.000112	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCND1—ocular cancer	9.73e-05	0.00011	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—ocular cancer	9.48e-05	0.000108	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDKN1A—ocular cancer	9.41e-05	0.000107	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCND1—ocular cancer	9.41e-05	0.000107	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCND1—ocular cancer	9.41e-05	0.000107	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—EP300—ocular cancer	9.32e-05	0.000106	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—ocular cancer	9.17e-05	0.000104	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—ocular cancer	9.17e-05	0.000104	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—ocular cancer	9.16e-05	0.000104	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDKN1A—ocular cancer	9.1e-05	0.000103	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDKN1A—ocular cancer	9.1e-05	0.000103	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EP300—ocular cancer	8.95e-05	0.000102	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—ocular cancer	8.86e-05	0.000101	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—ocular cancer	8.86e-05	0.000101	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—ocular cancer	8.75e-05	9.94e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—ocular cancer	8.74e-05	9.93e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EP300—ocular cancer	8.66e-05	9.84e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EP300—ocular cancer	8.66e-05	9.84e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—ocular cancer	8.47e-05	9.61e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—ocular cancer	8.47e-05	9.61e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—ocular cancer	8.37e-05	9.5e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—EP300—ocular cancer	8.12e-05	9.22e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—ocular cancer	8.1e-05	9.19e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—ocular cancer	8.1e-05	9.19e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MYC—ocular cancer	7.8e-05	8.86e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—ocular cancer	7.78e-05	8.84e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—ocular cancer	7.73e-05	8.78e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—EP300—ocular cancer	7.65e-05	8.69e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MYC—ocular cancer	7.55e-05	8.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MYC—ocular cancer	7.55e-05	8.57e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—ocular cancer	7.53e-05	8.55e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—ocular cancer	7.53e-05	8.55e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—ocular cancer	7.47e-05	8.49e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—ocular cancer	7.47e-05	8.49e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—ocular cancer	6.65e-05	7.55e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—ocular cancer	6.47e-05	7.35e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—ocular cancer	6.41e-05	7.28e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—ocular cancer	6.26e-05	7.11e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—ocular cancer	6.26e-05	7.11e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—ocular cancer	6.2e-05	7.04e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—ocular cancer	6.2e-05	7.04e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—ocular cancer	6.13e-05	6.96e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—ocular cancer	5.93e-05	6.73e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—ocular cancer	5.93e-05	6.73e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—ocular cancer	5.63e-05	6.39e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—ocular cancer	5.41e-05	6.15e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—ocular cancer	5.23e-05	5.94e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—ocular cancer	5.23e-05	5.94e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—EP300—ocular cancer	5e-05	5.68e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—ocular cancer	4.9e-05	5.57e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—ocular cancer	4.62e-05	5.25e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—ocular cancer	3.02e-05	3.43e-05	CbGpPWpGaD
